文献速递创伤与烧伤心脑血管急症

N-乙酰半胱氨酸与老年患者脑震荡后症状减轻相关:一项先导研究

N -acetylcysteine is associated with reduction of postconcussive symptoms in elderly patients: A pilot study.
PubMed 文献 · J Trauma Acute Care Surg · 2022-04-08
一句话结论在60岁及以上轻度脑外伤患者中,N-乙酰半胱氨酸组第7天和第30天的脑震荡后症状问卷评分显著低于仅标准治疗组。

这项前瞻性、准随机对照先导研究纳入60岁及以上轻度脑外伤患者,按就诊创伤中心分配至N-乙酰半胱氨酸加标准治疗组或仅标准治疗组,共分析65例(NAC组34例,对照组31例),平均年龄76±10岁。主要结局为Rivermeade脑震荡后症状问卷(RPQ)评分,于第0、7、30天评估。基线RPQ评分两组无显著差异(6[0-20] vs 11[4-20],p=0.300);第7天(2[0-8] vs 10[3-18],p=0.004)和第30天(0[0-4] vs 4[0-13],p=0.021)NAC组显著低于对照组;NAC组组内差异显著(p<0.001),对照组组内差异不显著(p=0.319)。作者认为结果支持进一步研究NAC治疗脑外伤。

要点

  • 纳入60岁及以上轻度脑外伤患者,排除伤后3小时内无法评估认知功能者,共分析65例(NAC组34例,对照组31例),平均年龄76±10岁。
  • 第7天RPQ评分NAC组2[0-8] vs 对照组10[3-18],p=0.004,NAC组显著更低。
  • 第30天RPQ评分NAC组0[0-4] vs 对照组4[0-13],p=0.021,NAC组显著更低。
  • 基线RPQ评分两组无显著差异(6[0-20] vs 11[4-20],p=0.300)。
  • NAC组组内RPQ评分差异显著(p<0.001),对照组组内差异不显著(p=0.319)。

适用人群与场景

  • 60岁及以上、诊断为轻度脑外伤的患者。
  • 排除伤后3小时内无法评估认知功能者。

诊断标准与关键阈值

  • 采用Rivermeade脑震荡后症状问卷(RPQ)评估脑震荡症状严重程度,于第0、7、30天评估。

处置流程与药物剂量

  • 按就诊创伤中心分配至N-乙酰半胱氨酸加标准治疗组或仅标准治疗组。

研究设计与关键结果

  • 前瞻性、准随机对照先导研究,共分析65例(NAC组34例,对照组31例),平均年龄76±10岁;基线人口学和临床变量相似,头部简明损伤定级评分和格拉斯哥昏迷评分无组间差异。
  • 基线RPQ评分NAC组6[0-20] vs 对照组11[4-20],p=0.300,两组无显著差异。
  • 第7天RPQ评分NAC组2[0-8] vs 对照组10[3-18],p=0.004,NAC组显著更低。
  • 第30天RPQ评分NAC组0[0-4] vs 对照组4[0-13],p=0.021,NAC组显著更低。
  • 组内差异:NAC组显著降低(p<0.001),对照组未达显著(p=0.319)。

证据类型、等级与局限

  • 证据类型:前瞻性、准随机对照先导研究;证据等级:治疗/照护管理,Level IV。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,N-乙酰半胱氨酸与老年轻度脑外伤患者脑震荡症状的显著改善相关,这些结果支持进一步研究使用NAC治疗脑外伤。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: N -acetylcysteine (NAC) may be neuroprotective by minimizing postconcussion symptoms after mild traumatic brain injury (TBI), but limited data exist. This study evaluated the effects of NAC on postconcussion symptoms in elderly patients diagnosed with mild TBI.

METHODS: This prospective, quasirandomized, controlled trial enrolled patients 60 years or older who suffered mild TBI. Patients were excluded if cognitive function could not be assessed within 3-hours postinjury. Patients were allocated to receive NAC plus standard care, or standard care alone, based on the trauma center where they presented. The primary study outcome was the severity of concussive symptoms measured using the Rivermeade Postconcussion Symptoms Questionnaire (RPQ). Symptoms were evaluated on days 0, 7, and 30. The RPQ scores were compared both within and between treatment groups.

RESULTS: There were 65 patients analyzed (NAC, n = 34; control, n = 31) with an average age of 76 ± 10 years. Baseline demographics and clinical variables were similar. No group differences in head Abbreviated Injury Scale score or Glasgow Coma Scale score were observed. Baseline RPQ scores (6 [0-20] vs. 11 [4-20], p = 0.300) were indistinguishable. The RPQ scores on day 7 (2 [0-8] vs. 10 [3-18], p = 0.004) and 30 (0 [0-4] vs. 4 [0-13], p = 0.021) were significantly lower in the NAC group. Within-group differences were significantly lower in the NAC ( p < 0.001) but not control group ( p = 0.319).

CONCLUSION: N -acetylcysteine was associated with significant improvements in concussion symptoms in elderly patients with mild TBI. These results justify further research into using NAC to treat TBI.

LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Mcpherson RA, Mangram AJ, Barletta JF, et al. N -acetylcysteine is associated with reduction of postconcussive symptoms in elderly patients: A pilot study. J Trauma Acute Care Surg. 2022. PMID: 35393384. doi:10.1097/TA.0000000000003639

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。